Advertisement

Clinical and Translational Oncology

, Volume 10, Issue 8, pp 517–521 | Cite as

Metastatic disease from chordoma

  • Gloria VergaraEmail author
  • Belén Belinchón
  • Francisco Valcárcel
  • María Veiras
  • Irma Zapata
  • Alejandro de la Torre
Case Reports

Abstract

Chordomas are tumors with a bad prognosis, because of their location, local aggressiveness and high rate of local relapse. Despite of be benign tumors, they have certain capacity of metastasize and a clinical evolution that results interesting. When we analyzed our series with 35 chordomas studied and treated between 1975 and 2002, we found three patients that experienced a systemic dissemination.

Keywords

Chordoma Metastases Radiotherapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sundaresan N, Boriani S, Rothman A, Holtzman R (2004) Tumors of the osseous spine. J Neurooncology 69:273–290CrossRefGoogle Scholar
  2. 2.
    Markwalder TM, Regula V, Markwalder RV et al (1979) Metastatic chordoma. Surg Neurol 12: 473–478PubMedGoogle Scholar
  3. 3.
    Soo MY (2001) Chordoma: review of clinicoradiological features and factors affecting survival. Australas Radiol 45:427–434PubMedCrossRefGoogle Scholar
  4. 4.
    Chetty RC, Levin VC, Kalan MR (1991) Chordoma: a 20-year clinicopathologic review of the experience at Groote Schuur Hospital, Cape Town. J Surg Oncol 46:261–264PubMedCrossRefGoogle Scholar
  5. 5.
    Fourney DR, Gokasian ZL (2003) Current management of sacral chordoma. Neurosurg Focus 15(2):E9PubMedCrossRefGoogle Scholar
  6. 6.
    McPherson CM, Suki D, McCutcheon IE et al (2006). Metastatic disease from spinal chordoma: a 10-year experience. J Neurosurg Spine 5:277–280PubMedCrossRefGoogle Scholar
  7. 7.
    McMaster ML, Goldstein AM, Bromley CM et al (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12(1):1–11PubMedCrossRefGoogle Scholar
  8. 8.
    Tai PT, Craighead P, Liem SK et al (2000) Management issues in chordoma: a case series. Clin On col (R Coll Radiol) 12(2):80–86Google Scholar
  9. 9.
    St. Martin M, Levine SC (2003) Chordomas of the skull base: manifestations and management. Curr Opin Otolaryngol Head Neck Surg 11:324–327PubMedCrossRefGoogle Scholar
  10. 10.
    Romero J, Cárdenes H, De la Torre A et al (1993) Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 29:27–32PubMedCrossRefGoogle Scholar
  11. 11.
    Catton C, O’sullivan B, Bell R et al (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67–72PubMedGoogle Scholar
  12. 12.
    Igaki H, Tokuuye K, Okumura T et al (2004) Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 60(4):1120–1126PubMedGoogle Scholar
  13. 13.
    Mendenhall WM, Mendenhall CM, Lewis SB et al (2005) Skull base chordoma. Head Neck 27(2):159–165PubMedCrossRefGoogle Scholar
  14. 14.
    Imai R, Kamada T, Tsuji H et al (2004) Carbon ion radiotherapy for unresectable sacral chordoma. Clin Cancer Res 10:5741–5746PubMedCrossRefGoogle Scholar
  15. 15.
    Casali PG, Stacchiotti S, Sangalli C et al (2007) Curr Opin Oncol 19:367–370PubMedCrossRefGoogle Scholar
  16. 16.
    Jacob HE (1994) Chemotherapy for cranial base tumors. J Neurooncol 20:327–335PubMedCrossRefGoogle Scholar
  17. 17.
    Schonegger K, Gelpi E, Prayer D et al (2005) Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progression. Anticancer Drugs 16(10):1139–1143PubMedCrossRefGoogle Scholar
  18. 18.
    Fleming GF, Heiman PS, Stephens JK et al (1993) Dedifferentiated chordoma: response to aggressive chemotherapy in two cases. Cancer 72:714–718PubMedCrossRefGoogle Scholar
  19. 19.
    Auger M, Raney B, Callender D et al (1994) Metastatic intracranial chordoma in a child with massive pulmonary tumor emboli. Fetal Pediatr Pathol 14:763–770CrossRefGoogle Scholar
  20. 20.
    Casali PG, Messina A, Stracchiotti S et al (2004) Imatinib mesylate in chordoma. Cancer 101: 2086–2097PubMedCrossRefGoogle Scholar
  21. 21.
    Hof H, Welzel T, Debus J (2006) Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 29:572–574PubMedCrossRefGoogle Scholar
  22. 22.
    Clinical Trial Phase II. Efficacy and Safety of Imatinib in Chordoma, Milano, Italy. Novartis. NCT00150072/CSTI571BIT15Google Scholar
  23. 23.
    Bergh P, Kindblom LG, Gutenberg B et al (2000) Prognostic factors in chordoma of the sacrum and mobile spine (39 patients). Cancer 88(9):2122–2134PubMedCrossRefGoogle Scholar
  24. 24.
    Chambers PW, Schwinn CP (1979) Chordoma. A clinicopathologic study of metastasis. Am J Clin Pa thol 72(5):765–776Google Scholar
  25. 25.
    St. Delank KS, Kriegsmann J, Drees PH et al (2002) Metastasising chordoma of the lumbar spine. Eur Spine J 11(2):167–171CrossRefGoogle Scholar
  26. 26.
    Higinbotham NL, Phillips RF, Farr HW, Husyu HO (1967) Chordoma. Thirty-five-year study at Memorial Hospital. Cancer 20:1841–1850PubMedCrossRefGoogle Scholar
  27. 27.
    Heffelfinger M J, Dahlin DC, MacCarty CS, Beabout JW (1973) Chordomas and cartilaginous tumors at the skull base. Cancer 32:410–420PubMedCrossRefGoogle Scholar
  28. 28.
    Asano S, Kawahara N, Kirino T (2003) Case report. Intradural spinal seeding of a clival chordoma. Acta Neurochir 145:599–603CrossRefGoogle Scholar
  29. 29.
    Baratti D, Gronchi A, Pennachioli E et al (2003) Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Onco 10:291–296CrossRefGoogle Scholar

Copyright information

© Feseo 2008

Authors and Affiliations

  • Gloria Vergara
    • 1
    Email author
  • Belén Belinchón
    • 1
  • Francisco Valcárcel
    • 1
  • María Veiras
    • 1
  • Irma Zapata
    • 1
  • Alejandro de la Torre
    • 1
  1. 1.Servicio de Oncología RadioterápicaHospital Puerta de HierroMadridSpain

Personalised recommendations